Huaihong Yuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Huaihong Yuan has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Ping Fu
Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China
13 shared publicationsYujie Yang
Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China
10 shared publicationsYang Chen
Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China
7 shared publicationsLinfang Zhu
Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China
6 shared publicationsYing Qiu
Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China
6 shared publicationsYing Zeng
Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China
6 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8784
Prognostic Factors for Mortality and Functional Prognosis in Hemodialysis Patients with Intracerebral Hemorrhage: A Systematic Review
Background: Evidence of mortality, functional prognosis, and prognostic factors among patients undergoing hemodialysis (HD) with spontaneous intracerebral hemorrhage (ICH) has not been systematically synthesized yet. Objectives: To systematically synthesize the independent prognostic factors associated with mortality and functional prognosis in patients undergoing HD with spontaneous ICH. Methods: A systematic review was conducted. Cohort and case–control studies were identified from PubMed, Web of Science, Scopus, Embase, CNKI, Wanfang Data, VIP, and SinoMed from inception to October 2025, with an updated search to June 2026. Study quality and risk of bias were assessed using the Newcastle–Ottawa Scale (NOS) and the Quality In Prognosis Studies (QUIPS) tool. The prognostic factors associated with mortality and functional prognosis were summarized. Results: Eight retrospective studies were included, comprising four cohort and four case–control studies. The methodological quality of the included studies was limited, with a high or moderate risk of bias in the study confounding domain across all studies and additional concerns in other domains. Mortality outcomes included in-hospital and 30-day mortality, whereas functional prognosis was assessed at discharge, 30 days, 90 days, or 6 months, primarily using the modified Rankin Scale (mRS). For mortality outcomes, the Glasgow Coma Scale (GCS) score, ICH volume, and HD vintage were examined in two studies. Other prognostic factors, including pupillary response, hematoma progression, demographic factors, hemodynamic factors, laboratory parameters, treatment-related factors, and clinical scores, were reported in the individual studies. For functional prognosis, ICH volume and GCS scores were evaluated in multiple studies, whereas age and hemoglobin levels were assessed in two studies. Other prognostic factors, including imaging characteristics, hemodynamic factors, laboratory parameters, treatment-related factors, and clinical scores, were reported in the individual studies. Conclusions: Various prognostic factors associated with mortality and functional prognosis have been reported in patients undergoing HD with spontaneous ICH. However, most factors were evaluated in individual studies, and repeated assessments were limited to a small number of factors, including the GCS score and ICH volume, for both mortality and functional prognosis. Neurological severity and hematoma volume therefore remain the most frequently investigated prognostic indicators, with a consistent direction of association across studies, although the underlying outcome definitions were not interchangeable; no dialysis-specific factor demonstrated replicated associations.
- 10 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8784
Open AccessPrognostic Factors for Mortality and Functional Prognosis in Hemodialysis Patients with Intracerebral Hemorrhage: A Systematic Review
Background: Evidence of mortality, functional prognosis, and prognostic factors among patients undergoing hemodialysis (HD) with spontaneous intracerebral hemorrhage (ICH) has not been systematically synthesized yet. Objectives: To systematically synthesize the independent prognostic factors associated with mortality and functional prognosis in patients undergoing HD with spontaneous ICH. Methods: A systematic review was conducted. Cohort and case–control studies were identified from PubMed, Web of Science, Scopus, Embase, CNKI, Wanfang Data, VIP, and SinoMed from inception to October 2025, with an updated search to June 2026. Study quality and risk of bias were assessed using the Newcastle–Ottawa Scale (NOS) and the Quality In Prognosis Studies (QUIPS) tool. The prognostic factors associated with mortality and functional prognosis were summarized. Results: Eight retrospective studies were included, comprising four cohort and four case–control studies. The methodological quality of the included studies was limited, with a high or moderate risk of bias in the study confounding domain across all studies and additional concerns in other domains. Mortality outcomes included in-hospital and 30-day mortality, whereas functional prognosis was assessed at discharge, 30 days, 90 days, or 6 months, primarily using the modified Rankin Scale (mRS). For mortality outcomes, the Glasgow Coma Scale (GCS) score, ICH volume, and HD vintage were examined in two studies. Other prognostic factors, including pupillary response, hematoma progression, demographic factors, hemodynamic factors, laboratory parameters, treatment-related factors, and clinical scores, were reported in the individual studies. For functional prognosis, ICH volume and GCS scores were evaluated in multiple studies, whereas age and hemoglobin levels were assessed in two studies. Other prognostic factors, including imaging characteristics, hemodynamic factors, laboratory parameters, treatment-related factors, and clinical scores, were reported in the individual studies. Conclusions: Various prognostic factors associated with mortality and functional prognosis have been reported in patients undergoing HD with spontaneous ICH. However, most factors were evaluated in individual studies, and repeated assessments were limited to a small number of factors, including the GCS score and ICH volume, for both mortality and functional prognosis. Neurological severity and hematoma volume therefore remain the most frequently investigated prognostic indicators, with a consistent direction of association across studies, although the underlying outcome definitions were not interchangeable; no dialysis-specific factor demonstrated replicated associations.
- 29 September 2026
- Published by Springer Nature in International Urology and Nephrology
- p. 1-20
Impact of neuromuscular electrical stimulation on physical performance, muscle strength, and body composition in hemodialysis patients: a meta-analysis of randomized and quasi-randomized controlled trials
Purpose To evaluate the effects of neuromuscular electrical stimulation (NMES) on physical performance, muscle strength, and body composition in patients undergoing hemodialysis. Methods Systematic searches were conducted across PubMed, Embase, Web of Science, and the Cochrane Library from their respective inceptions (earliest 1900) to March 31, 2026. Randomized and quasi-randomized controlled trials comparing NMES to usual care/sham NMES were eligible. Meta-analyses were performed for both post-intervention values and changes from baseline. Results Seventeen trials (comprising 19 reports; n = 403) were included, with NMES treatment durations ranging from 4 to 20 weeks. NMES significantly improved 6-min walk test distance in both post-intervention (MD = 43.12 m; 95% CI 18.17, 68.07) and change from baseline (MD = 37.00 m; 95% CI 11.88, 62.12) analyses. Gait speed demonstrated a significant increase in the change value analysis (MD = 0.19 m/s; 95% CI 0.10, 0.28), although post-intervention comparisons were non-significant. No significant improvements were observed in skeletal muscle mass, lean body mass, handgrip strength, or adiposity markers. NMES was well-tolerated, with no adverse effects on dialysis adequacy (Kt/V, change MD = − 0.07, 95% CI − 0.16, 0.01), electrolyte balance (e.g. potassium, change SMD = 0.14; 95% CI − 0.25, 0.53), or hemodynamic stability (e.g., systolic blood pressure, change MD = − 1.58 mmHg; 95% CI − 10.72, 7.56). Conclusion NMES is a safe and effective rehabilitative tool for enhancing exercise tolerance and functional walking capacity in patients undergoing hemodialysis, despite limited impact on muscle hypertrophy or body composition.
- 29 September 2026
- Published by Springer Nature in International Urology and Nephrology
- p. 1-20
Impact of neuromuscular electrical stimulation on physical performance, muscle strength, and body composition in hemodialysis patients: a meta-analysis of randomized and quasi-randomized controlled trials
Purpose To evaluate the effects of neuromuscular electrical stimulation (NMES) on physical performance, muscle strength, and body composition in patients undergoing hemodialysis. Methods Systematic searches were conducted across PubMed, Embase, Web of Science, and the Cochrane Library from their respective inceptions (earliest 1900) to March 31, 2026. Randomized and quasi-randomized controlled trials comparing NMES to usual care/sham NMES were eligible. Meta-analyses were performed for both post-intervention values and changes from baseline. Results Seventeen trials (comprising 19 reports; n = 403) were included, with NMES treatment durations ranging from 4 to 20 weeks. NMES significantly improved 6-min walk test distance in both post-intervention (MD = 43.12 m; 95% CI 18.17, 68.07) and change from baseline (MD = 37.00 m; 95% CI 11.88, 62.12) analyses. Gait speed demonstrated a significant increase in the change value analysis (MD = 0.19 m/s; 95% CI 0.10, 0.28), although post-intervention comparisons were non-significant. No significant improvements were observed in skeletal muscle mass, lean body mass, handgrip strength, or adiposity markers. NMES was well-tolerated, with no adverse effects on dialysis adequacy (Kt/V, change MD = − 0.07, 95% CI − 0.16, 0.01), electrolyte balance (e.g. potassium, change SMD = 0.14; 95% CI − 0.25, 0.53), or hemodynamic stability (e.g., systolic blood pressure, change MD = − 1.58 mmHg; 95% CI − 10.72, 7.56). Conclusion NMES is a safe and effective rehabilitative tool for enhancing exercise tolerance and functional walking capacity in patients undergoing hemodialysis, despite limited impact on muscle hypertrophy or body composition.
- Open Access
- 4 September 2026
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 27 (1) , 767
Screening effect of phase angle and calf circumference in different stages of sarcopenia in patients with maintenance hemodialysis
Complicated testing procedures, high costs and heavy clinical workloads limit routine sarcopenia screening. Patients with different sarcopenia stages prese
- 4 September 2026
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 27 (1) , 767
Open AccessScreening effect of phase angle and calf circumference in different stages of sarcopenia in patients with maintenance hemodialysis
Complicated testing procedures, high costs and heavy clinical workloads limit routine sarcopenia screening. Patients with different sarcopenia stages prese
- Open Access
- 3 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 26495
Network analysis of mental health literacy and depressive/anxiety symptoms in patients under maintenance hemodialysis: a cross-sectional study of multicenter data
To explore the network structures and gender differences of mental health literacy (MHL) and depressive/anxiety symptoms in maintenance hemodialysis (MHD) patients and identify core symptoms and bridge symptoms. We used convenience sampling to recruit 757 MHD patients from 6 hospitals in Sichuan Province, China. The Patient Health Questionnaire (PHQ-9), the Generalized Anxiety Disorder Scale (GAD-7), and the Chinese version of the Multidimensional Mental Health Literacy Scale (MMHL) were used for assessment. A network model was constructed, with centrality indicators and bridge strength calculated, network comparison tests and stability and accuracy tests were performed. The total score of MHL significantly negatively correlates with depressive symptoms (r = -0.22) and anxiety (r = -0.18). PHQ4 (Feeling tired or having little energy) and GAD4 (Trouble relaxing) showed higher strength centrality (1.205 and 1.184 respectively), while the strength of MHL2 (beliefs) was relatively high in the MHL cluster (0.546). In the bridge symptom analysis, the bridge strength of MHL2 (beliefs) was the highest (0.253), and PHQ3 (Trouble falling or staying asleep, or sleeping too much) was the key bridge symptom (0.143). Of note, significant difference was observed in the network structure between genders (p = 0.034). Our study mapped the complex interplay between MHL and depressive/anxiety symptoms in MHD patients. Fatigue is the core symptom, while the beliefs dimension of MHL and sleep problems are the key bridging symptoms. Future interventions should focus on fatigue, sleep, enhancing MHL knowledge, and reshaping positive beliefs, while considering gender-specific factors.
- 3 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 26495
Open AccessNetwork analysis of mental health literacy and depressive/anxiety symptoms in patients under maintenance hemodialysis: a cross-sectional study of multicenter data
To explore the network structures and gender differences of mental health literacy (MHL) and depressive/anxiety symptoms in maintenance hemodialysis (MHD) patients and identify core symptoms and bridge symptoms. We used convenience sampling to recruit 757 MHD patients from 6 hospitals in Sichuan Province, China. The Patient Health Questionnaire (PHQ-9), the Generalized Anxiety Disorder Scale (GAD-7), and the Chinese version of the Multidimensional Mental Health Literacy Scale (MMHL) were used for assessment. A network model was constructed, with centrality indicators and bridge strength calculated, network comparison tests and stability and accuracy tests were performed. The total score of MHL significantly negatively correlates with depressive symptoms (r = -0.22) and anxiety (r = -0.18). PHQ4 (Feeling tired or having little energy) and GAD4 (Trouble relaxing) showed higher strength centrality (1.205 and 1.184 respectively), while the strength of MHL2 (beliefs) was relatively high in the MHL cluster (0.546). In the bridge symptom analysis, the bridge strength of MHL2 (beliefs) was the highest (0.253), and PHQ3 (Trouble falling or staying asleep, or sleeping too much) was the key bridge symptom (0.143). Of note, significant difference was observed in the network structure between genders (p = 0.034). Our study mapped the complex interplay between MHL and depressive/anxiety symptoms in MHD patients. Fatigue is the core symptom, while the beliefs dimension of MHL and sleep problems are the key bridging symptoms. Future interventions should focus on fatigue, sleep, enhancing MHL knowledge, and reshaping positive beliefs, while considering gender-specific factors.
- Open Access
- 22 May 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1832983
Self-perceptions of aging and associated factors among older patients undergoing maintenance hemodialysis: a latent profile analysis
Background: Self-perceptions of aging (SPA) were significantly associated with adverse health outcomes in older adults. However, whether SPA among older patients undergoing maintenance hemodialysis (MHD) exhibits distinct latent profiles and what variables are associated with these subgroups remain to be clarified. Objective: This study aimed to identify the latent profiles of SPA and examine their related factors among older MHD patients. Methods: A secondary analysis was carried out on a cross-sectional study. A convenience sampling method was employed to recruit older MHD patients from four hemodialysis centers in Sichuan Province, China. Data were collected using a demographic information form, the Brief Aging Perceptions Questionnaire (B-APQ), the Social Frailty Scale (SFS), and the 5-item Geriatric Depression Scale (GDS-5). Latent profile analysis was employed to identify distinct subgroups of SPA, and binary logistic regression was adopted to explore factors associated with subgroup membership. Results: A total of 381 older MHD patients were included in this study. Two latent profiles were identified and were designated as the “positive self-perceptions of aging group (36.5%)” and “negative self-perceptions of aging group (63.5%).” Age ≤ 70 years was negatively associated with the negative self-perceptions of aging group (OR = 0.56, 95% CI: 0.34–0.93, p = 0.024), while depression (OR = 1.96, 95% CI: 1.15–3.32, p = 0.013) and social frailty (OR = 3.21, 95% CI: 2.00–5.15, p < 0.001) were positively associated with that group. Conclusion: A multi-level support system involving healthcare providers, family members, and community resources should be established to address the psychological needs of older MHD patients and mitigate negative perceptions of aging.
- 22 May 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1832983
Open AccessSelf-perceptions of aging and associated factors among older patients undergoing maintenance hemodialysis: a latent profile analysis
Background: Self-perceptions of aging (SPA) were significantly associated with adverse health outcomes in older adults. However, whether SPA among older patients undergoing maintenance hemodialysis (MHD) exhibits distinct latent profiles and what variables are associated with these subgroups remain to be clarified. Objective: This study aimed to identify the latent profiles of SPA and examine their related factors among older MHD patients. Methods: A secondary analysis was carried out on a cross-sectional study. A convenience sampling method was employed to recruit older MHD patients from four hemodialysis centers in Sichuan Province, China. Data were collected using a demographic information form, the Brief Aging Perceptions Questionnaire (B-APQ), the Social Frailty Scale (SFS), and the 5-item Geriatric Depression Scale (GDS-5). Latent profile analysis was employed to identify distinct subgroups of SPA, and binary logistic regression was adopted to explore factors associated with subgroup membership. Results: A total of 381 older MHD patients were included in this study. Two latent profiles were identified and were designated as the “positive self-perceptions of aging group (36.5%)” and “negative self-perceptions of aging group (63.5%).” Age ≤ 70 years was negatively associated with the negative self-perceptions of aging group (OR = 0.56, 95% CI: 0.34–0.93, p = 0.024), while depression (OR = 1.96, 95% CI: 1.15–3.32, p = 0.013) and social frailty (OR = 3.21, 95% CI: 2.00–5.15, p < 0.001) were positively associated with that group. Conclusion: A multi-level support system involving healthcare providers, family members, and community resources should be established to address the psychological needs of older MHD patients and mitigate negative perceptions of aging.
- Open Access
- 27 March 2026
- Published by Springer Nature in BMC Nephrology
- Vol. 27 (1)
Development and validation of a nomogram for identifying pre-frailty risk in middle-aged and elderly maintenance hemodialysis patients: a cross-sectional study
This study aimed to develop a nomogram for screening the risk of pre-frailty in middle-aged and elderly patients on maintenance hemodialysis (MHD) based on
- 27 March 2026
- Published by Springer Nature in BMC Nephrology
- Vol. 27 (1)
Open AccessDevelopment and validation of a nomogram for identifying pre-frailty risk in middle-aged and elderly maintenance hemodialysis patients: a cross-sectional study
This study aimed to develop a nomogram for screening the risk of pre-frailty in middle-aged and elderly patients on maintenance hemodialysis (MHD) based on
- Open Access
- 29 October 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Plantar pressure distribution can be used to identify sarcopenia in maintenance hemodialysis patients
Patients undergoing maintenance hemodialysis (MHD) often suffer from sarcopenia, which affects their balance and significantly increases the risk of falls and death. Actively identifying sarcopenia, understanding the relationship between sarcopenia and the distribution of plantar pressure and balance ability in MHD patients, and reducing the risk of unstable falls are crucial. This study aims to develop an auxiliary screening model for sarcopenia in MHD patients based on machine learning methods using plantar pressure biomechanical indicators, while also paying attention to the gender difference and exploring its value in screening for sarcopenia. This study was a cross-sectional study. Data were collected from MHD patients receiving care at a hemodialysis center in China. The Asian Working Group for Sarcopenia consensus updated in 2019 was used to assess whether MHD patients had sarcopenia. Plantar pressure distribution was measured using a plantar pressure plate for MHD patients with their feet-together and separated by 10 cm. Patients were grouped into the sarcopenia and control group and grouped into three gender groups (mixed-gender group, male group, and female group). Comprehensive physiological indicators, including the patient’s basic information, body measurements, and laboratory test results, were also collected to enhance model accuracy. After statistical analysis and feature selection, stratified shuffling split and synthetic minority oversampling technique were used to develop auxiliary screening classifiers for sarcopenia. A total of 184 MHD patients’ data were collected, including 95 males (40 with possible sarcopenia or sarcopenia) and 89 females (57 with possible sarcopenia or sarcopenia). Three binary classification models were developed for the mixed-gender group (mean age of 53.66), male group (mean age of 53.43), and female group (mean age of 53.91), respectively, using plantar pressure biomechanical indicators. The area under the receiver operating characteristic curve (AUC) values for the three models were 75%, 72%, and 82%, respectively. The use of plantar pressure indicators in the feet-together stance, when combined with comprehensive physiological indicators (age and pre-dialysis creatinine), further improved the accuracy of the auxiliary screening model (AUC values of up to 78% and 88%, respectively). Plantar pressure indicators have high value in the screening of sarcopenia in MHD patients. When using plantar pressure indicators of the feet-together and feet-separated by 10 cm stance, a mixed-gender model should be chosen to obtain better screening results. In addition, if clinical conditions allow it, more accurate results for the screening of sarcopenia can be obtained by combining comprehensive physiological indicators with plantar pressure indicators of the feet-together stance. Trial registration: Chinese Clinical Trial Registry (ChiCTR2100051111), registered on 20,210,913.
- 29 October 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Open AccessPlantar pressure distribution can be used to identify sarcopenia in maintenance hemodialysis patients
Patients undergoing maintenance hemodialysis (MHD) often suffer from sarcopenia, which affects their balance and significantly increases the risk of falls and death. Actively identifying sarcopenia, understanding the relationship between sarcopenia and the distribution of plantar pressure and balance ability in MHD patients, and reducing the risk of unstable falls are crucial. This study aims to develop an auxiliary screening model for sarcopenia in MHD patients based on machine learning methods using plantar pressure biomechanical indicators, while also paying attention to the gender difference and exploring its value in screening for sarcopenia. This study was a cross-sectional study. Data were collected from MHD patients receiving care at a hemodialysis center in China. The Asian Working Group for Sarcopenia consensus updated in 2019 was used to assess whether MHD patients had sarcopenia. Plantar pressure distribution was measured using a plantar pressure plate for MHD patients with their feet-together and separated by 10 cm. Patients were grouped into the sarcopenia and control group and grouped into three gender groups (mixed-gender group, male group, and female group). Comprehensive physiological indicators, including the patient’s basic information, body measurements, and laboratory test results, were also collected to enhance model accuracy. After statistical analysis and feature selection, stratified shuffling split and synthetic minority oversampling technique were used to develop auxiliary screening classifiers for sarcopenia. A total of 184 MHD patients’ data were collected, including 95 males (40 with possible sarcopenia or sarcopenia) and 89 females (57 with possible sarcopenia or sarcopenia). Three binary classification models were developed for the mixed-gender group (mean age of 53.66), male group (mean age of 53.43), and female group (mean age of 53.91), respectively, using plantar pressure biomechanical indicators. The area under the receiver operating characteristic curve (AUC) values for the three models were 75%, 72%, and 82%, respectively. The use of plantar pressure indicators in the feet-together stance, when combined with comprehensive physiological indicators (age and pre-dialysis creatinine), further improved the accuracy of the auxiliary screening model (AUC values of up to 78% and 88%, respectively). Plantar pressure indicators have high value in the screening of sarcopenia in MHD patients. When using plantar pressure indicators of the feet-together and feet-separated by 10 cm stance, a mixed-gender model should be chosen to obtain better screening results. In addition, if clinical conditions allow it, more accurate results for the screening of sarcopenia can be obtained by combining comprehensive physiological indicators with plantar pressure indicators of the feet-together stance. Trial registration: Chinese Clinical Trial Registry (ChiCTR2100051111), registered on 20,210,913.
- Open Access
Comparative Efficacy of pHA130 Haemoadsorption Combined with Haemodialysis Versus Online Haemodiafiltration in Removing Protein-Bound and Middle-Molecular-Weight Uraemic Toxins: A Randomized Controlled Trial
Protein-bound uraemic toxins (PBUTs), such as indoxyl sulphate (IS) and p-cresyl sulphate (PCS), are poorly cleared by conventional haemodialysis (HD) or haemodiafiltration (HDF). Haemoadsorption combined with HD (HAHD) using the novel pHA130 cartridge may increase PBUT removal, and this trial aimed to compare its efficacy and safety with HDF in patients with end-stage renal disease (ESRD). In this single-centre, open-label trial, 30 maintenance HD patients were randomized (1:1:1) to HDF once every two weeks (HDF-q2w), HAHD once every two weeks (HAHD-q2w), or HAHD once weekly (HAHD-q1w) for 8 weeks, with the primary endpoint being the single-session reduction ratio (RR) of IS. The combined HAHD group (n = 20) demonstrated a significantly greater IS reduction than the HDF-q2w group (n = 10) (46.9% vs. 31.8%; p = 0.044) and superior PCS clearance (44.6% vs. 31.4%; p = 0.003). Both HAHD regimens significantly reduced predialysis IS levels at Week 8. Compared with HDF, weekly HAHD provided greater relief from pruritus and improved sleep quality, with comparable adverse events among groups. In conclusion, HAHD with the pHA130 cartridge is more effective than HDF for enhancing single-session PBUT removal and alleviating uraemic symptoms in patients with ESRD, with weekly application showing optimal symptomatic benefits.
Open AccessComparative Efficacy of pHA130 Haemoadsorption Combined with Haemodialysis Versus Online Haemodiafiltration in Removing Protein-Bound and Middle-Molecular-Weight Uraemic Toxins: A Randomized Controlled Trial
Protein-bound uraemic toxins (PBUTs), such as indoxyl sulphate (IS) and p-cresyl sulphate (PCS), are poorly cleared by conventional haemodialysis (HD) or haemodiafiltration (HDF). Haemoadsorption combined with HD (HAHD) using the novel pHA130 cartridge may increase PBUT removal, and this trial aimed to compare its efficacy and safety with HDF in patients with end-stage renal disease (ESRD). In this single-centre, open-label trial, 30 maintenance HD patients were randomized (1:1:1) to HDF once every two weeks (HDF-q2w), HAHD once every two weeks (HAHD-q2w), or HAHD once weekly (HAHD-q1w) for 8 weeks, with the primary endpoint being the single-session reduction ratio (RR) of IS. The combined HAHD group (n = 20) demonstrated a significantly greater IS reduction than the HDF-q2w group (n = 10) (46.9% vs. 31.8%; p = 0.044) and superior PCS clearance (44.6% vs. 31.4%; p = 0.003). Both HAHD regimens significantly reduced predialysis IS levels at Week 8. Compared with HDF, weekly HAHD provided greater relief from pruritus and improved sleep quality, with comparable adverse events among groups. In conclusion, HAHD with the pHA130 cartridge is more effective than HDF for enhancing single-session PBUT removal and alleviating uraemic symptoms in patients with ESRD, with weekly application showing optimal symptomatic benefits.
- Open Access
- 19 May 2025
- Published by Springer Nature in BMC Nephrology
- Vol. 26 (1) , 1-14
Gender-specific sarcopenia screening in hemodialysis: insights from lower limb strength and physiological indicators
Maintenance hemodialysis (MHD) patients often suffer from sarcopenia, affecting lower limb muscle strength and increasing the risk of falls and mortality. This study aims to develop an auxiliary screening model for sarcopenia in MHD patients based on machine learning methods, utilizing lower limb muscle strength indicators, while paying attention to the gender difference and exploring its value in sarcopenia screening. This cross-sectional study collected data from MHD patients at a hemodialysis center in China. Sarcopenia was assessed using the 2019 Asian Working Group for Sarcopenia update. A self-developed lower limb muscle strength testing device was used. Other physiological indicators, including basic information and lab findings, were collected. Participants were grouped into sarcopenia and control groups, with gender-specific binary classification models developed. Stratified shuffling and synthetic minority oversampling techniques were used to build screening classifiers. Data from 164 MHD patients were ultimately collected, including 83 males (41 with possible sarcopenia or sarcopenia) and 81 females (53 with possible sarcopenia or sarcopenia). Gender-specific binary classification models were developed using lower limb muscle strength indicators, with the male model having an AUC of 79% and the female model an AUC of 80%, respectively. Combining lower limb muscle strength with other physiological indicators improved the female model’s screening capability, achieving an AUC of 90%. This study demonstrates that the auxiliary screening model for sarcopenia, developed using machine learning methods, highlights the significant value of lower limb muscle strength indicators in identifying sarcopenia in MHD patients. The gender-specific screening models show good discriminatory ability across different genders, providing effective tools for the early screening and management of sarcopenia in MHD patients. Chinese Clinical Trial Registry (ChiCTR2100051111), registered on 2021–09–13.
- 19 May 2025
- Published by Springer Nature in BMC Nephrology
- Vol. 26 (1) , 1-14
Open AccessGender-specific sarcopenia screening in hemodialysis: insights from lower limb strength and physiological indicators
Maintenance hemodialysis (MHD) patients often suffer from sarcopenia, affecting lower limb muscle strength and increasing the risk of falls and mortality. This study aims to develop an auxiliary screening model for sarcopenia in MHD patients based on machine learning methods, utilizing lower limb muscle strength indicators, while paying attention to the gender difference and exploring its value in sarcopenia screening. This cross-sectional study collected data from MHD patients at a hemodialysis center in China. Sarcopenia was assessed using the 2019 Asian Working Group for Sarcopenia update. A self-developed lower limb muscle strength testing device was used. Other physiological indicators, including basic information and lab findings, were collected. Participants were grouped into sarcopenia and control groups, with gender-specific binary classification models developed. Stratified shuffling and synthetic minority oversampling techniques were used to build screening classifiers. Data from 164 MHD patients were ultimately collected, including 83 males (41 with possible sarcopenia or sarcopenia) and 81 females (53 with possible sarcopenia or sarcopenia). Gender-specific binary classification models were developed using lower limb muscle strength indicators, with the male model having an AUC of 79% and the female model an AUC of 80%, respectively. Combining lower limb muscle strength with other physiological indicators improved the female model’s screening capability, achieving an AUC of 90%. This study demonstrates that the auxiliary screening model for sarcopenia, developed using machine learning methods, highlights the significant value of lower limb muscle strength indicators in identifying sarcopenia in MHD patients. The gender-specific screening models show good discriminatory ability across different genders, providing effective tools for the early screening and management of sarcopenia in MHD patients. Chinese Clinical Trial Registry (ChiCTR2100051111), registered on 2021–09–13.
- Open Access
- 24 February 2025
- Published by Springer Nature in BMC Nephrology
- Vol. 26 (1) , 1-9
Prevalence, associated factors and clinical implications of subjective cognitive decline linked to frailty in patients receiving maintenance hemodialysis: a cross-sectional study
Subjective cognitive decline (SCD) significantly increases a patient’s risk of long-term cognitive decline and is common in adults. However, few studies have evaluated patients with end-stage renal disease receiving maintenance hemodialysis (MHD). In addition, the relationship between frailty and SCD in MHD patients remains unclear. Therefore, this study aimed to assess the potential factors affecting SCD in MHD patients and to investigate the relationship between frailty and SCD. This was a cross-sectional study. From December 2023 to April 2024, via the convenience sampling method, a total of 171 patients from West China Hospital of Sichuan University were recruited to participate in this study. The demographic and sociological characteristics of the participants were assessed via a general information questionnaire. The subjective cognitive decline questionnaire 9 (SCD-Q9), the Tilburg frailty indicator (TFI), the subjective global nutritional assessment (SGA) and the grip dynamometer were used to assess the participants’ subjective cognitive level, frailty, nutritional status, and grip strength, respectively. Univariate analyses were used to examine potential factors associated with SCD. Linear regression was used to analyze the relationships between these factors and SCD. Spearman’s correlation was used to assess the association between SCD and frailty. The average subjective cognitive decline score of the 171 MHD patients was 4.00 (2.00–7.00), and 95 patients (55.56%) with scores > 3 presented with SCD. Linear regression analysis revealed that sex, work status, grip strength, SGA, and frailty were influential factors in MHD patients, explaining 38.80% of the total variation in SCD. Spearman’s analysis revealed that SCD was positively correlated with frailty in MHD patients (r = 0.431, P < 0.001). The prevalence of SCD in MHD patients is common and correlates with certain patient characteristics, including sex, work status, grip strength, SGA, and frailty. Healthcare workers should pay attention to the assessment of subjective cognitive function in this population, remain aware of the risk factors for SCD, and take targeted interventions as early as possible, which can help improve the quality of survival and slow the occurrence of cognitive impairment.
- 24 February 2025
- Published by Springer Nature in BMC Nephrology
- Vol. 26 (1) , 1-9
Open AccessPrevalence, associated factors and clinical implications of subjective cognitive decline linked to frailty in patients receiving maintenance hemodialysis: a cross-sectional study
Subjective cognitive decline (SCD) significantly increases a patient’s risk of long-term cognitive decline and is common in adults. However, few studies have evaluated patients with end-stage renal disease receiving maintenance hemodialysis (MHD). In addition, the relationship between frailty and SCD in MHD patients remains unclear. Therefore, this study aimed to assess the potential factors affecting SCD in MHD patients and to investigate the relationship between frailty and SCD. This was a cross-sectional study. From December 2023 to April 2024, via the convenience sampling method, a total of 171 patients from West China Hospital of Sichuan University were recruited to participate in this study. The demographic and sociological characteristics of the participants were assessed via a general information questionnaire. The subjective cognitive decline questionnaire 9 (SCD-Q9), the Tilburg frailty indicator (TFI), the subjective global nutritional assessment (SGA) and the grip dynamometer were used to assess the participants’ subjective cognitive level, frailty, nutritional status, and grip strength, respectively. Univariate analyses were used to examine potential factors associated with SCD. Linear regression was used to analyze the relationships between these factors and SCD. Spearman’s correlation was used to assess the association between SCD and frailty. The average subjective cognitive decline score of the 171 MHD patients was 4.00 (2.00–7.00), and 95 patients (55.56%) with scores > 3 presented with SCD. Linear regression analysis revealed that sex, work status, grip strength, SGA, and frailty were influential factors in MHD patients, explaining 38.80% of the total variation in SCD. Spearman’s analysis revealed that SCD was positively correlated with frailty in MHD patients (r = 0.431, P < 0.001). The prevalence of SCD in MHD patients is common and correlates with certain patient characteristics, including sex, work status, grip strength, SGA, and frailty. Healthcare workers should pay attention to the assessment of subjective cognitive function in this population, remain aware of the risk factors for SCD, and take targeted interventions as early as possible, which can help improve the quality of survival and slow the occurrence of cognitive impairment.